Abstract:
The decision in Daubert v Merrell Dow Pharmaceuticals 509 US 579 (1993) brought about renewed
attention to and scrutiny of fingerprint comparison evidence in the United States of America. In terms of
the decision courts were to act as the gatekeepers with respect to the admissibility of scientific expert
evidence. This article describes these events and investigates the grounds upon which challenges were
made to fingerprint comparison evidence in the courts, as well as the position that was taken by the courts.
The article also considers the fundamental test for the admission of expert evidence, and whether the
critique pointed out by the defendants in the cases with regard to reliability are sufficiently penetrating to
warrant the exclusion of fingerprint comparison evidence.